Hyderabad: Pharma player Hetero announced that its biologics arm ‘Hetero Biopharma’ has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture Sputnik Light. Hetero is the first biopharmaceutical company in India to receive manufacturing and marketing (M&M) approval for the product manufactured locally for the prevention of COVID-19 in adults aged over […]
The Gamaleya Center and RDIF announced on November 24 positive results obtained during the second interim data analysis of the largest double-blind, randomised, placebo-controlled Phase III clinical trials in Russia’s history involving 40,000 volunteers.